1.
Pilia AM, Salvati L, Guidolin A, Mazzoni F, Antonuzzo L, Parronchi P, Liotta F. Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: a first case report. Swiss Med Wkly [Internet]. 2024 Mar. 4 [cited 2024 May 8];154(3):3513. Available from: https://smw.ch/index.php/smw/article/view/3513